復銳醫療科技(01696.HK)附屬於巴塞隆拿舉行第六屆Alma Academy線下活動 接待全球近400名醫生
復銳醫療科技(01696.HK)宣布,旗下子公司Alma成功在巴塞隆拿舉行一連4日(3月1日至4日)第六屆Alma Academy線下活動,並會上接待了來自全球37個國家的近400名醫生。
復銳醫療科技表示,是次活動邀請來自行業的16位全球頂級專家,共同探討行業熱門話題、分享行業見解並交流真實案例的實務研究,另外亦吸引行業內各個細分領域的專業人士參加,包括皮膚科醫生、美容醫生、整容外科醫生和整形外科醫生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.